Thelarche Variant

Key points
- This encompasses a spectrum of conditions, which lie between premature thelarche and central precocious puberty.
- It may be difficult to distinguish from central precocious puberty.
- Indeed, there is a complete spectrum of gonadotrophin secretion in these conditions between LH and FSH dominance.
- This condition has been described under different names, which has led to confusion.
Thelarche Variant
This encompasses a spectrum of conditions, which lie between premature thelarche and central precocious puberty. It may be difficult to distinguish from central precocious puberty. Indeed, there is a complete spectrum of gonadotrophin secretion in these conditions between LH and FSH dominance. This condition has been described under different names, which has led to confusion. It has been known as unsustained precocious puberty, slowly progressive precocious puberty, thelarche variant and exaggerated thelarche. In all these conditions, there is a similar clinical description of breast development, which is similar to that seen in premature thelarche, although the breast cycling is less common.
There is usually pubic hair development, so that the condition cannot be classified as 'isolated' premature thelarche. However, the rate of growth is usually faster than normal, but without an advanced epiphyseal maturation. Growth prognosis appears to be normal, or near normal. The breast development frequently arrests and, certainly, does not advance to full sexual maturation. Behavioural problems are unusual. The condition only requires reassurance, but if treatment with a GnRH analogue is attempted, it may well result in a change of sexual maturation to central precocious puberty.
Patients with this condition of thelarche variant have often been included in patients with central precocious puberty and analysed contemporaneously in their response to GnRH analogue. As the growth prognosis is normal in the thelarche variant, it may well have compromised the analysis of patients with central precocious puberty and produced results which have suggested that GnRH analogue therapy produces an artificially improved benefit in terms of final height attainment. As this condition was only described a decade ago, there are no studies about the effect into adult life and longer-term studies will need to be undertaken.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
NewsMenopause Symptoms Not Eased by Calcium, Vitamin D
Supplementation with calcium and vitamin D does not appear to influence the number of menopause-related vasomotor, mood, or sleep symptoms in older women, according to a new study. A secondary analysis of the Women's…
10 June 2015
NewsHormones Soon After Menopause Do Not Affect Cognition
Menopausal hormone therapy (MHT) for up to 4 years after the last menstrual period did not improve cognition but did improve some mood symptoms, according to results of a study published online June 2 in PLOS Medicine.…
4 June 2015
NewsVitamin D and calcium supplements do not improve menopausal symptoms
Women who took vitamin D and calcium supplements had the same number of menopausal symptoms as women who did not take the supplements, according to a study published today in Maturitas, the official journal of the…




